LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Sep 15, 2023
Discovery & Translation
Mini Cas protein iterations; plus Moderna’s Lassa virus vaccine and more
BioCentury’s roundup of translational innovations
Read More
BioCentury
|
Jul 2, 2021
Distillery Therapeutics
A single-shot, measles-vectored vaccine for Lassa virus
DISEASE CATEGORY: Infectious disease
INDICATION: Viral hemorrhagic fever Vaccination with a measles virus vector expressing
Lassa virus glycoprotein
and nucleoprotein could prevent Lassa virus
Read More
BioCentury
|
Sep 27, 2017
Distillery Therapeutics
Infectious disease
Read More
BioCentury
|
Sep 6, 2017
Preclinical News
Human mAbs could treat Lassa fever
Read More
Items per page:
10
1 - 4 of 4